VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1565692
Sex: M
Age: 90
State: FL

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Fluid in his arm; If he puts his elbow down it hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Fluid in his arm) and ARTHRALGIA (If he puts his elbow down it hurts) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The patient's past medical history included Pacemaker insertion (cardiac) (pacemaker, and had surgery 4 years ago), Knee replacement and Shoulder replacement. Concurrent medical conditions included Heart disease, unspecified and Artificial cardiac pacemaker user. On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Fluid in his arm) and ARTHRALGIA (If he puts his elbow down it hurts). At the time of the report, VACCINATION SITE SWELLING (Fluid in his arm) and ARTHRALGIA (If he puts his elbow down it hurts) outcome was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness: Artificial cardiac pacemaker user; Heart disease, unspecified

ID: 1565693
Sex: F
Age:
State: FL

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: she come across with term called "COVID ARM". She read about it. She seems like that is what she had; it was very itchy; bright red patch in injection site, 8 inches long 4 inches wide; it was warmer than rest of my skin; same day achy arm lasted for day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (same day achy arm lasted for day), INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for an unknown indication. No Medical History information was reported. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (same day achy arm lasted for day). On 18-Feb-2021, the patient experienced INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide). On an unknown date, the patient experienced VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had). On 16-Feb-2021, PAIN IN EXTREMITY (same day achy arm lasted for day) had resolved. On 01-Mar-2021, INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide) had resolved. At the time of the report, VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were given. Treatment information include benadryl liquid and anti itch cream. This case was linked to US-MODERNATX, INC.-MOD-2021-041286 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-041286:Dose 2 case

Other Meds:

Current Illness:

ID: 1565694
Sex: M
Age:
State: NY

Vax Date: 03/05/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: severe muscle spasm; Cannot turn the head to the right, left or up, it had a very limited range of motion; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (severe muscle spasm) and MUSCULOSKELETAL STIFFNESS (Cannot turn the head to the right, left or up, it had a very limited range of motion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 80777 0273-99) for COVID-19 vaccination. No Medical History information was reported. Concomitant products included LOSARTAN, ROSUVASTATIN, CLOPIDOGREL, PROPRANOLOL, ATENOLOL, FLUOXETINE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced MUSCLE SPASMS (severe muscle spasm) and MUSCULOSKELETAL STIFFNESS (Cannot turn the head to the right, left or up, it had a very limited range of motion). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and DIAZEPAM (VALIUM) for Muscle spasm, at a dose of 10 milligram. At the time of the report, MUSCLE SPASMS (severe muscle spasm) and MUSCULOSKELETAL STIFFNESS (Cannot turn the head to the right, left or up, it had a very limited range of motion) was resolving. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: LOSARTAN; ROSUVASTATIN; CLOPIDOGREL; PROPRANOLOL; ATENOLOL; FLUOXETINE; BABY ASPIRIN

Current Illness:

ID: 1565695
Sex: F
Age: 27
State: LA

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Left arm is still a little tender; Left arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm is still a little tender) and VACCINATION SITE PAIN (Left arm was a little sore) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The patient's past medical history included Clotting disorder (Diagnosed on 2009 or 2010). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL PALMITATE, RIBOFLAVIN, THIAMINE MONONITRATE (MULTIVITAMIN 6) for an unknown indication. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (Left arm was a little sore). On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Left arm is still a little tender). At the time of the report, VACCINATION SITE PAIN (Left arm is still a little tender) and VACCINATION SITE PAIN (Left arm was a little sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were provided.

Other Meds: BABY ASPIRIN; MULTIVITAMIN 6

Current Illness:

ID: 1565696
Sex: F
Age: 63
State: TX

Vax Date: 03/11/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Pain in arms; Body aches; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1565697
Sex: F
Age: 71
State: AZ

Vax Date: 02/11/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Swollen Arm - Near Injection Site; Arm Pain - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 015M20A) for COVID-19 vaccination. Concomitant products included IBUPROFEN for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site). At the time of the report, VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site) outcome was unknown. No treatment information was provided.

Other Meds: IBUPROFEN

Current Illness:

ID: 1565698
Sex: F
Age: 77
State: TX

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: On the injection site she had a pretty wide area bruised; On the injection site she had a pretty wide area red; On the injection site she had a pretty wide area swollen; Pain from a 1 to 10 scale was 1; The area spread in red color; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (On the injection site she had a pretty wide area bruised), VACCINATION SITE ERYTHEMA (On the injection site she had a pretty wide area red), VACCINATION SITE SWELLING (On the injection site she had a pretty wide area swollen), PAIN (Pain from a 1 to 10 scale was 1) and ERYTHEMA (The area spread in red color) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LOSARTAN, NORTRIPTYLINE, METOPROLOL, OMEPRAZOLE and RALOXIFENE for an unknown indication. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE BRUISING (On the injection site she had a pretty wide area bruised), VACCINATION SITE ERYTHEMA (On the injection site she had a pretty wide area red), VACCINATION SITE SWELLING (On the injection site she had a pretty wide area swollen), PAIN (Pain from a 1 to 10 scale was 1) and ERYTHEMA (The area spread in red color). At the time of the report, VACCINATION SITE BRUISING (On the injection site she had a pretty wide area bruised), VACCINATION SITE ERYTHEMA (On the injection site she had a pretty wide area red), VACCINATION SITE SWELLING (On the injection site she had a pretty wide area swollen), PAIN (Pain from a 1 to 10 scale was 1) and ERYTHEMA (The area spread in red color) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: LOSARTAN; NORTRIPTYLINE; METOPROLOL; OMEPRAZOLE; RALOXIFENE

Current Illness:

ID: 1565699
Sex: M
Age: 48
State: NV

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: pain in opposite arm; Fatigue; Chills; Pain in arm; Difficult to lift arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm,), LIMB DISCOMFORT (Difficult to lift arm), PAIN IN EXTREMITY (pain in opposite arm), FATIGUE (Fatigue) and CHILLS (Chills) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm,), LIMB DISCOMFORT (Difficult to lift arm), FATIGUE (Fatigue) and CHILLS (Chills). On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in opposite arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm,), LIMB DISCOMFORT (Difficult to lift arm), PAIN IN EXTREMITY (pain in opposite arm), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1565700
Sex: F
Age: 73
State: AZ

Vax Date: 03/09/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Throat pain; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Throat pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. Concomitant products included FISH OIL (OMEGA 3 [FISH OIL]) and VITAMINS NOS for an unknown indication. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Throat pain). The patient was treated with AMOXICILLIN on 11-Mar-2021 at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Throat pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: OMEGA 3 [FISH OIL]; VITAMINS NOS

Current Illness:

ID: 1565701
Sex: F
Age:
State: LA

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Co-administered with tetanus and rabies shot; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DRUG INTERACTION (Co-administered with tetanus and rabies shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Cat bite since 11-Mar-2021. Concomitant products included TETANUS VACCINE TOXOID (TETANUS) from 11-Mar-2021 to 11-Mar-2021, RABIES VACCINE (RABIES VACCIN) from 11-Mar-2021 to an unknown date and ANTIBIOTICS from 11-Mar-2021 to an unknown date for Animal bite. On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced DRUG INTERACTION (Co-administered with tetanus and rabies shot). At the time of the report, DRUG INTERACTION (Co-administered with tetanus and rabies shot) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. After being administered the second dose of the COVID vaccine, the patient reported to the nurse that she was bit by a cat before coming to her appointment and was at urgent care, where she received a tetanus shot and was started on an antibiotic. Also, the patient's doctor's office found out that one hour after the patient received her COVID vaccine, she went to the Emergency Room, as she still had pain from the cat bite. There, she was given the "3 series" rabies shot. Treatment information was not reported.

Other Meds: TETANUS; RABIES VACCIN; ANTIBIOTICS

Current Illness: Cat bite

ID: 1565702
Sex: F
Age:
State: SC

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Received first dose and less than 18 years of age; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received first dose and less than 18 years of age) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received first dose and less than 18 years of age). On 05-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received first dose and less than 18 years of age) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reporter did not allow further contact; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number 027A21A) with no associated AEs reported.

Other Meds:

Current Illness:

ID: 1565703
Sex: M
Age: 70
State: AZ

Vax Date: 02/02/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Little soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little soreness at injection site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Little soreness at injection site). At the time of the report, VACCINATION SITE PAIN (Little soreness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Relevant concomitant medications were not reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1565704
Sex: M
Age: 55
State: NV

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: 3 pretty nasty nosebleeds; Runny/ wet nose; Felt like he needed to curl up into a ball on bed; Massive, excruciating pains in both his arms and legs; Headache; Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs) and HEADACHE (Headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included METFORMIN, CARVEDILOL, LISINOPRIL, PREGABALIN, ATORVASTATIN and INSULIN GLARGINE (LANTUS) for an unknown indication. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs), HEADACHE (Headache) and ARTHRALGIA (Sore shoulder). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Mar-2021, EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs), HEADACHE (Headache) and ARTHRALGIA (Sore shoulder) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: METFORMIN; CARVEDILOL; LISINOPRIL; PREGABALIN; ATORVASTATIN; LANTUS

Current Illness:

ID: 1565705
Sex: M
Age:
State: AL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Pain in his arm; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in his arm) and PYREXIA (Low grade fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Tooth infection since an unknown date. Concomitant products included ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for an unknown indication. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in his arm) and PYREXIA (Low grade fever). At the time of the report, PAIN IN EXTREMITY (Pain in his arm) and PYREXIA (Low grade fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Other concomitant medications include antibiotics for tooth infection. No Treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: FOLLOW-UP information received on 22-JUN-2021. Updated the events Pain in Arm and Low grade fever from unknown to Resolved.

Other Meds: NEXIUM [ESOMEPRAZOLE MAGNESIUM]

Current Illness: Tooth infection

ID: 1565706
Sex: F
Age: 31
State: PA

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Headache; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (body aches) and CHILLS (chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (Headache), MYALGIA (body aches) and CHILLS (chills). At the time of the report, HEADACHE (Headache), MYALGIA (body aches) and CHILLS (chills) outcome was unknown. No concomitant medications were provided. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1565707
Sex: F
Age: 73
State: ID

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Red rash down her arm; Red rash down her arm; Swelling of arm at injection site; Fatigue; Headaches; Nausea; Fever; Heated at injection site; Sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE WARMTH (Heated at injection site), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red rash down her arm), RASH (Red rash down her arm) and VACCINATION SITE SWELLING (Swelling of arm at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Heated at injection site), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Swelling of arm at injection site), FATIGUE (Fatigue), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (Fever). On 12-Mar-2021, the patient experienced ERYTHEMA (Red rash down her arm) and RASH (Red rash down her arm). At the time of the report, VACCINATION SITE WARMTH (Heated at injection site) and VACCINATION SITE SWELLING (Swelling of arm at injection site) outcome was unknown and PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red rash down her arm), RASH (Red rash down her arm), FATIGUE (Fatigue), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (Fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant products also included Fomamox for an unknow indication. The patient stated that she had swelling of arm, and heated at injection site. She also had a red rash down her arm, and sore for a couple of days. According to the patient, she had fatigue, headaches, nausea and fever for 2 days. No treatment information was provided.

Other Meds: LEXAPRO

Current Illness:

ID: 1565708
Sex: F
Age:
State: TX

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Still having a temperature of 101; vaccination site erythema; Fever; Chills; Soreness in injection site; Warm to touch; Muscle aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE PAIN (Soreness in injection site), INJECTION SITE WARMTH (Warm to touch) and MYALGIA (Muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse reaction. On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 11-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE PAIN (Soreness in injection site), INJECTION SITE WARMTH (Warm to touch), MYALGIA (Muscle aches) and ERYTHEMA (Red). On an unknown date, the patient experienced PYREXIA (Still having a temperature of 101). At the time of the report, PYREXIA (Fever), CHILLS (Chills), INJECTION SITE WARMTH (Warm to touch), MYALGIA (Muscle aches), PYREXIA (Still having a temperature of 101) and ERYTHEMA (Red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.

Other Meds:

Current Illness:

ID: 1565709
Sex: M
Age: 46
State: GA

Vax Date: 03/11/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: 100.2 temperature; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (100.2 temperature) and CHILLS (Chills) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D32M20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (100.2 temperature) and CHILLS (Chills). At the time of the report, PYREXIA (100.2 temperature) and CHILLS (Chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1565710
Sex: F
Age: 59
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Rash all over her body; A spontaneous report was received from a consumer concerning a 59-years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rash all over her body/ rash. The patient's medical history included high blood pressure. Products known to have been used by the patient, within two weeks prior to the event, included lisinopril. On 25 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 031L20A) intramuscularly for prophylaxis of COVID-19 infection. On 25 Feb 2021, the patient experienced allergic reaction of rash all over her body. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not provided. The outcome of event rash all over her body was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded

Other Meds: LISINOPRIL

Current Illness: Blood pressure high

ID: 1565711
Sex: F
Age: 74
State: MD

Vax Date: 03/05/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Blood in the urine; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD URINE PRESENT (Blood in the urine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was reported. Concomitant products included FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY ELLIPTA), SALBUTAMOL (ALBUTEROL HFA) and PRAVASTATIN for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD URINE PRESENT (Blood in the urine). The patient was treated with NITROFURANTOIN at an unspecified dose and frequency. At the time of the report, BLOOD URINE PRESENT (Blood in the urine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient went to healthcare professional for urine analysis.

Other Meds: TRELEGY ELLIPTA; ALBUTEROL HFA; PRAVASTATIN

Current Illness:

ID: 1565712
Sex: F
Age: 75
State:

Vax Date: 01/19/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination. No medical history was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Not applicable The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided by the reporter. Treatment Shingles medications The patient had the second dose scheduled on 14-Feb-2021. A week prior of the administration of the second dose, the patient developed shingles and received shingles medications as a treatment. The vaccination provider told her to not receive the vaccine until the medication was over.

Other Meds:

Current Illness:

ID: 1565713
Sex: F
Age:
State:

Vax Date: 03/09/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: rash around neck and chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash around neck and chest) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash around neck and chest). At the time of the report, RASH (rash around neck and chest) outcome was unknown. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. No concomitant medication was reported No treatment medication was reported

Other Meds:

Current Illness:

ID: 1565714
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Chills; Fevers; Headaches; A spontaneous report was received from a 63-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, fevers/pyrexia and headaches. The patient's medical history included Rheumatoid arthritis. Concomitant product use was not provided. On unknown date, prior to the onset of the events, the patient received first of two planned doses of mRNA-1273 (lot/batch: 030M20A) Intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, after receiving the first dose, the patient experienced chills, fevers and headaches.Symptoms improved after about 36 hours. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events, chills, fevers and headaches was resolving at the time of this report.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: ENBREL

Current Illness: Rheumatoid arthritis

ID: 1565715
Sex: F
Age: 58
State: NC

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: arm hot at injection site; arm red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (arm hot at injection site) and INJECTION SITE ERYTHEMA (arm red at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced INJECTION SITE WARMTH (arm hot at injection site) and INJECTION SITE ERYTHEMA (arm red at injection site). At the time of the report, INJECTION SITE WARMTH (arm hot at injection site) and INJECTION SITE ERYTHEMA (arm red at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication use was provided by the reporter. Treatment of events was not reported.

Other Meds:

Current Illness:

ID: 1565716
Sex: F
Age: 84
State: FL

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: ache in the upper arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (ache in the upper arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. Concurrent medical conditions included Cholesterol, Blood pressure high and Platelets abnormal. Concomitant products included MAGNESIUM, CALCIUM and VITAMIN D NOS for an unknown indication. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (ache in the upper arm). At the time of the report, PAIN IN EXTREMITY (ache in the upper arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Additional concomitant medications reported since an unknown start date included medicines for cholesterol, platelet and blood pressure indications. Treatment of events was not reported though the patient did call to confirm if she could take acetaminophen (Tylenol).

Other Meds: MAGNESIUM; CALCIUM; VITAMIN D NOS

Current Illness: Blood pressure high; Cholesterol; Platelets abnormal

ID: 1565717
Sex: F
Age: 73
State: NC

Vax Date: 02/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 032M204) for COVID-19 vaccination. The patient's past medical history included Arthritis. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced ARTHRALGIA (Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine). At the time of the report, ARTHRALGIA (Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1565718
Sex: F
Age: 64
State: NY

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Last week, had rash on right arm, light red, circular in nature; sore arm ? felt like someone beating my arm in a fight; ingers on both hands felt numb and tingling for couple of minutes; stomach was off; absolutely had no energy; felt pretty lousy after the first dose; headachy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm ? felt like someone beating my arm in a fight), HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy) and FATIGUE (felt pretty lousy after the first dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Sjogren's syndrome, Hashimoto's disease, Joint inflammation, Osteoporosis and Osteoarthritis. Concomitant products included COLECALCIFEROL (vitamin D), FOLIC ACID, vitamin c and folic acid and CALCIUM CITRATE for an unknown indication. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm ? felt like someone beating my arm in a fight), HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy), FATIGUE (felt pretty lousy after the first dose) and HEADACHE (headachy). On an unknown date, the patient experienced RASH (Last week, had rash on right arm, light red, circular in nature). On 27-Feb-2021, HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes) had resolved. On 01-Mar-2021, PAIN IN EXTREMITY (sore arm ? felt like someone beating my arm in a fight), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy), FATIGUE (felt pretty lousy after the first dose) and HEADACHE (headachy) had resolved. At the time of the report, RASH (Last week, had rash on right arm, light red, circular in nature) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medication details was reported. This case was linked to MOD-2021-060899 (Patient Link).

Other Meds: vitamin D; FOLIC ACID; vitamin c and folic acid; CALCIUM CITRATE

Current Illness:

ID: 1565719
Sex: F
Age:
State: AL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: FELT CONFUSED AND OUT OF IT; ARM FELT LIKE FEVER IN IT; Fever; ARM VERY RED; RASH; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (FELT CONFUSED AND OUT OF IT), VACCINATION SITE WARMTH (ARM FELT LIKE FEVER IN IT), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (ARM VERY RED) and VACCINATION SITE RASH (RASH) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (FELT CONFUSED AND OUT OF IT), VACCINATION SITE WARMTH (ARM FELT LIKE FEVER IN IT), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (ARM VERY RED) and VACCINATION SITE RASH (RASH). At the time of the report, CONFUSIONAL STATE (FELT CONFUSED AND OUT OF IT), VACCINATION SITE WARMTH (ARM FELT LIKE FEVER IN IT), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (ARM VERY RED) and VACCINATION SITE RASH (RASH) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1565720
Sex: F
Age: 38
State: FL

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: feels like a ball in her throat; Chest is very tight; Stomach pain; Weird pain deep in ear through the core of her crown of her head like electricity; Had a hard time breathing; Very itchy; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Had a hard time breathing), PRURITUS (Very itchy), ABDOMINAL PAIN UPPER (Stomach pain), EAR PAIN (Weird pain deep in ear through the core of her crown of her head like electricity) and OROPHARYNGEAL DISCOMFORT (feels like a ball in her throat) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DYSPNOEA (Had a hard time breathing) and PRURITUS (Very itchy). On 09-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and EAR PAIN (Weird pain deep in ear through the core of her crown of her head like electricity). On 12-Mar-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (feels like a ball in her throat) and CHEST DISCOMFORT (Chest is very tight). On 09-Mar-2021, PRURITUS (Very itchy) had resolved. On 11-Mar-2021, ABDOMINAL PAIN UPPER (Stomach pain) and EAR PAIN (Weird pain deep in ear through the core of her crown of her head like electricity) had resolved. At the time of the report, DYSPNOEA (Had a hard time breathing), OROPHARYNGEAL DISCOMFORT (feels like a ball in her throat) and CHEST DISCOMFORT (Chest is very tight) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided aside from asthma inhaler. Treatment of events as reported by patient included use of asthma Inhaler.

Other Meds:

Current Illness: Asthma

ID: 1565721
Sex: F
Age: 53
State: NJ

Vax Date: 01/28/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: second dose not administered yet; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not administered yet) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not administered yet). On 12-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not administered yet) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information was not provided by reporter.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot #: Unknown) with no associated AEs.

Other Meds:

Current Illness:

ID: 1565722
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Patients get the vaccines which were previously shaken; Vaccine boxes are not secured in the refrigerator; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT PREPARATION ISSUE (Patients get the vaccines which were previously shaken) and EXPIRED PRODUCT ADMINISTERED (Vaccine boxes are not secured in the refrigerator) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT PREPARATION ISSUE (Patients get the vaccines which were previously shaken) and EXPIRED PRODUCT ADMINISTERED (Vaccine boxes are not secured in the refrigerator). At the time of the report, PRODUCT PREPARATION ISSUE (Patients get the vaccines which were previously shaken) and EXPIRED PRODUCT ADMINISTERED (Vaccine boxes are not secured in the refrigerator) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1565723
Sex: F
Age: 61
State: OK

Vax Date: 03/08/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Fast heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heartbeat) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEART RATE INCREASED (Fast heartbeat). At the time of the report, HEART RATE INCREASED (Fast heartbeat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. Concomitant product use was unknown by the reporter

Other Meds:

Current Illness:

ID: 1565724
Sex: F
Age: 77
State: OK

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Left arm with mild symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Left arm with mild symptoms) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Left arm with mild symptoms). At the time of the report, VACCINATION COMPLICATION (Left arm with mild symptoms) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. No treatment information was provided. This case was linked to MOD-2021-042753 (Patient Link).

Other Meds:

Current Illness:

ID: 1565725
Sex: F
Age: 69
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Arm became swollen; Arm was little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was little sore) and VACCINATION SITE SWELLING (Arm became swollen) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 101A21A) for COVID-19 vaccination. No medical history is provided and concomitant are produced. Concomitant products included OLODATEROL HYDROCHLORIDE, TIOTROPIUM BROMIDE MONOHYDRATE (STIOLTO RESPIMAT) for an unknown indication. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm was little sore). On 10-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Arm became swollen). On 04-Mar-2021, VACCINATION SITE PAIN (Arm was little sore) had resolved. At the time of the report, VACCINATION SITE SWELLING (Arm became swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: STIOLTO RESPIMAT

Current Illness:

ID: 1565726
Sex: M
Age: 69
State: NH

Vax Date: 03/01/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: "COVID arm"; rash circling the injection site; sensitivity and itching in the injection site; sensitivity in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("COVID arm"), VACCINATION SITE RASH (rash circling the injection site), VACCINATION SITE PRURITUS (sensitivity and itching in the injection site) and VACCINATION SITE PAIN (sensitivity in the injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE REACTION ("COVID arm"), VACCINATION SITE RASH (rash circling the injection site), VACCINATION SITE PRURITUS (sensitivity and itching in the injection site) and VACCINATION SITE PAIN (sensitivity in the injection site). At the time of the report, VACCINATION SITE REACTION ("COVID arm"), VACCINATION SITE RASH (rash circling the injection site), VACCINATION SITE PRURITUS (sensitivity and itching in the injection site) and VACCINATION SITE PAIN (sensitivity in the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication use was provided by the reporter. Patient reported no treatment for events was provided.

Other Meds:

Current Illness:

ID: 1565727
Sex: M
Age:
State:

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Back pain; Muscle pain; Fever/ at 8am fever is gone back up; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), PYREXIA (Fever/ at 8am fever is gone back up) and MYALGIA (Muscle pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PYREXIA (Fever/ at 8am fever is gone back up). On an unknown date, the patient experienced BACK PAIN (Back pain) and MYALGIA (Muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, BACK PAIN (Back pain) and MYALGIA (Muscle pain) outcome was unknown and PYREXIA (Fever/ at 8am fever is gone back up) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. The patient experienced fever gave paracetamol at 5am and went down. But on 12-Mar-2021, at 8am it is gone back up. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1565728
Sex: F
Age: 33
State: TX

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The patient's past medical history included Alcohol use in December 2020. Family history included Dwarfism (Mother had one child with dwarfism with no bones. Did not survive.) and Congenital heart disease NOS (Sister-in-law had a baby with heart syndrome. Did not survive.). Concurrent medical conditions included Penicillin allergy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy. On 12-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 15-Dec-2020 and the estimated date of delivery was 21-Sep-2021. On 12-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twelfth week of the pregnancy. On 12-Mar-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Pregnancy test: positive (Positive) Positive. On 05-Mar-2021, Ultrasound uterus: on track (normal) On track. In 2021, Ultrasound uterus: positive (Positive) Positive pregnancy confirmation at 6 weeks. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. NIPT (Noninvasive Prenatal Testing) was performed on 05-Mar-2021, results are pending. Estimated Date of Conception: 29-Dec-2020

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness: Penicillin allergy

ID: 1565729
Sex: F
Age: 24
State: TX

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Tenderness and soreness at injection site, extremely tender; Redness at injection site on her upper arm, today her arm is super red; Arm where she received the injection had issues; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Arm where she received the injection had issues), VACCINATION SITE PAIN (Tenderness and soreness at injection site, extremely tender) and VACCINATION SITE ERYTHEMA (Redness at injection site on her upper arm, today her arm is super red) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION COMPLICATION (Arm where she received the injection had issues). On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Tenderness and soreness at injection site, extremely tender) and VACCINATION SITE ERYTHEMA (Redness at injection site on her upper arm, today her arm is super red). On 04-Mar-2021, VACCINATION COMPLICATION (Arm where she received the injection had issues) had resolved. At the time of the report, VACCINATION SITE PAIN (Tenderness and soreness at injection site, extremely tender) and VACCINATION SITE ERYTHEMA (Redness at injection site on her upper arm, today her arm is super red) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 12-Mar-2021, her arm where she received the vaccine was super red, extremely tender. Concomitant product used was not provided by the reporter. The patient did not receive any treatment medications.

Other Meds:

Current Illness:

ID: 1565730
Sex: F
Age: 71
State: ID

Vax Date: 01/27/2021
Onset Date: 02/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Rosacea; Decrease range of motion and strength in arm; Little swelling; Decrease range of motion and strength in arm; Pain in shoulder, more localized to muscle of the injection site, increased pain; Chills; This spontaneous case was reported by a nurse and describes the occurrence of ROSACEA (Rosacea), HYPOKINESIA (Decrease range of motion and strength in arm), PERIPHERAL SWELLING (Little swelling), MUSCULAR WEAKNESS (Decrease range of motion and strength in arm) and ARTHRALGIA (Pain in shoulder, more localized to muscle of the injection site, increased pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (Chills). On 09-Mar-2021, the patient experienced ROSACEA (Rosacea), HYPOKINESIA (Decrease range of motion and strength in arm), PERIPHERAL SWELLING (Little swelling), MUSCULAR WEAKNESS (Decrease range of motion and strength in arm) and ARTHRALGIA (Pain in shoulder, more localized to muscle of the injection site, increased pain). The patient was treated with PENICILLIN NOS on 09-Mar-2021 for Rosacea, at an unspecified dose and frequency. On 24-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, ROSACEA (Rosacea), HYPOKINESIA (Decrease range of motion and strength in arm), PERIPHERAL SWELLING (Little swelling), MUSCULAR WEAKNESS (Decrease range of motion and strength in arm) and ARTHRALGIA (Pain in shoulder, more localized to muscle of the injection site, increased pain) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. This case was linked to MOD-2021-042783 (Patient Link).

Other Meds:

Current Illness:

ID: 1565731
Sex: F
Age: 17
State: AZ

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Vaccination on patient under 18 y/o; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccination on patient under 18 y/o) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No medical history reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccination on patient under 18 y/o). On 12-Feb-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccination on patient under 18 y/o) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient was doing well and did not experience an adverse reaction to the vaccine. Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Reporters details, patient demographics and event information updated.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number unknown) with no associated AEs reported.

Other Meds:

Current Illness:

ID: 1565732
Sex: F
Age: 63
State: OK

Vax Date: 02/08/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Sleepy; swollen; soreness; red; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), SWELLING (swollen), PAIN (soreness), ERYTHEMA (red) and PRURITUS (Itchy) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Sleepy), SWELLING (swollen), PAIN (soreness), ERYTHEMA (red) and PRURITUS (Itchy). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, SOMNOLENCE (Sleepy), SWELLING (swollen), PAIN (soreness), ERYTHEMA (red) and PRURITUS (Itchy) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication use was provided by the reporter.

Other Meds:

Current Illness:

ID: 1565733
Sex: F
Age: 75
State: NY

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Terrible red rash that is the size of the grapefruit; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Terrible red rash that is the size of the grapefruit) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Terrible red rash that is the size of the grapefruit). At the time of the report, RASH ERYTHEMATOUS (Terrible red rash that is the size of the grapefruit) had resolved. No concomitant medication was reported. Patient did not receive any treatment for the event. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: TCR : AE outcome updated to recovered. No treatment was received. The patient received second dose without any issues.

Other Meds:

Current Illness:

ID: 1565734
Sex: F
Age: 69
State: NY

Vax Date: 03/01/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: r rash spreading underneath her arm and approaching the elbow; Rash on her chest; Hard around injection site; Painful around injection site; Ache on the shoulder; Arm swollen around injection site; Hot around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swollen around injection site), VACCINATION SITE WARMTH (Hot around injection site), CONDITION AGGRAVATED (r rash spreading underneath her arm and approaching the elbow), RASH (Rash on her chest) and VACCINATION SITE INDURATION (Hard around injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Allergy to chemicals (sulfur), Allergy (FLAXEN) and Shellfish allergy. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm swollen around injection site) and RASH (Rash on her chest). 03-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot around injection site), VACCINATION SITE INDURATION (Hard around injection site), VACCINATION SITE PAIN (Painful around injection site) and ARTHRALGIA (Ache on the shoulder). On 09-Mar-2021, the patient experienced CONDITION AGGRAVATED (r rash spreading underneath her arm and approaching the elbow). At the time of the report, PERIPHERAL SWELLING (Arm swollen around injection site), VACCINATION SITE WARMTH (Hot around injection site), VACCINATION SITE INDURATION (Hard around injection site), VACCINATION SITE PAIN (Painful around injection site) and ARTHRALGIA (Ache on the shoulder) had not resolved, CONDITION AGGRAVATED (r rash spreading underneath her arm and approaching the elbow) outcome was unknown and RASH (Rash on her chest) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medication were reported. Most recent FOLLOW-UP information incorporated above includes: On 14-Mar-2021: Follow up received on 14 march 2021, Reporter Email id and alternate phone number has been updated, Added allergies sulfur, Flaxen and shellfish, updated drug start date from 02-MAR-2021 to 01-MAR-2021. Added additional events rash spreading underneath her arm and rash approaching the elbow.

Other Meds:

Current Illness: Allergy (FLAXEN); Allergy to chemicals (sulfur); Shellfish allergy

ID: 1565735
Sex: M
Age: 78
State: UT

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Swelling at throat; Swelling...tongue; Swelling...lips; Could not swallow well , now is better but is still having difficulties for talk and swallow; Could not talk well , now is better but is still having difficulties for talk and swallow; Reports headache; This spontaneous case was reported by an other caregiver and describes the occurrence of OROPHARYNGEAL SWELLING (Swelling at throat), SWOLLEN TONGUE (Swelling...tongue), LIP SWELLING (Swelling...lips), DYSPHAGIA (Could not swallow well , now is better but is still having difficulties for talk and swallow) and SPEECH DISORDER (Could not talk well , now is better but is still having difficulties for talk and swallow) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced OROPHARYNGEAL SWELLING (Swelling at throat), SWOLLEN TONGUE (Swelling...tongue), LIP SWELLING (Swelling...lips), DYSPHAGIA (Could not swallow well , now is better but is still having difficulties for talk and swallow), SPEECH DISORDER (Could not talk well , now is better but is still having difficulties for talk and swallow) and HEADACHE (Reports headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL SWELLING (Swelling at throat), SWOLLEN TONGUE (Swelling..tongue), LIP SWELLING (Swelling..lips), DYSPHAGIA (Could not swallow well , now is better but is still having difficulties for talk and swallow), SPEECH DISORDER (Could not talk well , now is better but is still having difficulties for talk and swallow) and HEADACHE (Reports headache) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication use was provided by the reporter.

Other Meds:

Current Illness:

ID: 1565736
Sex: F
Age: 65
State: NY

Vax Date: 03/08/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Aches in legs), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Pretty much on bed and could not do anything) and ARTHRALGIA (Aches in Hips) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Aches in legs), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Pretty much on bed and could not do anything) and ARTHRALGIA (Aches in Hips). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Aches in legs), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Pretty much on bed and could not do anything) and ARTHRALGIA (Aches in Hips) outcome was unknown. No concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: follow up document received on 23-06-2021. contain Non significant information On 28-Jun-2021: Reporter contact information updated.

Other Meds:

Current Illness:

ID: 1565737
Sex: U
Age:
State: MD

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: This spontaneous case was reported by a nurse and describes the occurrence of RASH (rash on back, rash on torso), PRURITUS (itchy), VACCINATION SITE RASH (Rash at injection site) and URTICARIA (hives) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced RASH (rash on back, rash on torso), PRURITUS (itchy), VACCINATION SITE RASH (Rash at injection site) and URTICARIA (hives). At the time of the report, RASH (rash on back, rash on torso), PRURITUS (itchy) and VACCINATION SITE RASH (Rash at injection site) had not resolved and URTICARIA (hives) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. A nurse practitioner called on behalf of a patient to report events. No concomitant medication use was provided by the reporter. Treatment of events was not reported.

Other Meds:

Current Illness:

ID: 1565738
Sex: F
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (flare up on the knee). At the time of the report, ARTHRALGIA (flare up on the knee) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1565739
Sex: F
Age: 74
State: OR

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: muscles aching; light headed; distressed; like her brain is not working; arthritis been magnified; more tired than usual; dizzy; Disorientation; mild tenderness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Disorientation), VACCINATION SITE PAIN (mild tenderness on the injection site), MYALGIA (muscles aching), DIZZINESS (light headed) and EMOTIONAL DISTRESS (distressed) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (mild tenderness on the injection site). On 10-Mar-2021, the patient experienced DISORIENTATION (Disorientation), MYALGIA (muscles aching), DIZZINESS (light headed), EMOTIONAL DISTRESS (distressed), FEELING ABNORMAL (like her brain is not working), ARTHRITIS (arthritis been magnified), FATIGUE (more tired than usual) and DIZZINESS (dizzy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DISORIENTATION (Disorientation), FATIGUE (more tired than usual) and DIZZINESS (dizzy) had not resolved and VACCINATION SITE PAIN (mild tenderness on the injection site), MYALGIA (muscles aching), DIZZINESS (light headed), EMOTIONAL DISTRESS (distressed), FEELING ABNORMAL (like her brain is not working) and ARTHRITIS (arthritis been magnified) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported that the patient had received her 1st dose of vaccine on the left non-dominant arm. No concomitant medication was reported.

Other Meds:

Current Illness:

ID: 1565740
Sex: F
Age: 33
State: MI

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: pain, redness, and swelling at injection site; pain, redness, and swelling at injection site; pain, redness, and swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain, redness, and swelling at injection site), VACCINATION SITE ERYTHEMA (pain, redness, and swelling at injection site) and VACCINATION SITE SWELLING (pain, redness, and swelling at injection site) in a 33-year-old female patient who received mRNA-1273 (batch no. 029A21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain, redness, and swelling at injection site), VACCINATION SITE ERYTHEMA (pain, redness, and swelling at injection site) and VACCINATION SITE SWELLING (pain, redness, and swelling at injection site). The patient was treated with IBUPROFEN at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (pain, redness, and swelling at injection site), VACCINATION SITE ERYTHEMA (pain, redness, and swelling at injection site) and VACCINATION SITE SWELLING (pain, redness, and swelling at injection site) had not resolved. The action taken with mRNA-1273 (Intramuscular) was unknown. No concomitant medications were reported. This case was linked to MOD-2021-042533 (Patient Link).

Other Meds:

Current Illness:

ID: 1565741
Sex: F
Age: 68
State: IL

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Sore arm; Chills; Swelling; Redness; Itching on her left arm (wrist and hand); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), INJECTION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness) and PRURITUS (Itching on her left arm (wrist and hand)) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), INJECTION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness) and PRURITUS (Itching on her left arm (wrist and hand)). At the time of the report, PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), INJECTION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness) and PRURITUS (Itching on her left arm (wrist and hand)) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant Medication was provided. No treatment was provided. This case was linked to US-MODERNATX, INC.-MOD-2021-046607 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up received on 07-MAY-2021 and contains event itching on her left arm (wrist and hand). Update all events to resolved.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm